跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLODIPINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AMLODIPINE
Authorized
STANDARD
AMLODIPINE
altamed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
128ceb3719c6b86f
Company
altamed pharma
Type
Standard
Approval Details
Approval Id
128ceb3719c6b86f
Drug Approval Canada Name
AMLODIPINE
Product Name
AMLODIPINE
Status
Marketed
Status Date
2024-10-25
Original Market Date
2019-12-30
Din
02490803
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.08
Atc Original
C08CA01 AMLODIPINE
Atc Name
c 08 ca 01
Aig Number
0131437002
Company Name
altamed pharma
Company Address
151 Boulevard De Mortagne, Boucherville, Quebec, Canada, J4B 6G4
Active Ingredients
AMLODIPINE (AMLODIPINE BESYLATE)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
128ceb3719c6b86f
Type
Standard
Back to Health Canada Approvals